Real-world analysis of biomarker testing and use of targeted therapies in metastatic non-small cell lung cancer (mNSCLC) in the United States (US)

被引：0
|
作者：
Dennis, Michael J.
Abrahami, Devin
Vieira, Maria Cecilia
Benjumea, Darrin
Boyd, Marley
Shao, Anran
Duncan, Kirsten
Kelton, John
Patel, Sandip P.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-2552
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2552
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Real-world costs and outcomes associated with biomarker testing by comprehensive genomic profiling (CGP) and non-CGP approaches among patients with metastatic non-small cell lung cancer (mNSCLC)
    Byfield, Stacey DaCosta
    Bapat, Bela
    Becker, Laura
    Reyes, Carolina
    Chatzitheofilou, Ismini
    Hostin, Damon
    Schroeder, Brock
    Fox, John Leonard
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] REAL-WORLD BIOMARKER TESTING RATES IN METASTATIC COLORECTAL CANCER IN THE UNITED STATES
    Vieira, M. C.
    Haniszewski, M.
    Abraham, A.
    Kelton, J.
    Weber, C.
    Edwards, M.
    VALUE IN HEALTH, 2021, 24 : S49 - S50
  • [23] Targeted/Emerging Therapies for Metastatic Non-Small Cell Lung Cancer
    Horn, Leora
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (5.5): : 676 - 678
  • [24] New Targeted Therapies for Metastatic Non-Small Cell Lung Cancer
    Riely, Gregory J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22
  • [25] Real-world treatment patterns, biomarker testing, and clinical outcomes of metastatic non-small cell lung cancer patients in the immunotherapy era
    Apter, Lior
    Moser, Sarah Sharman
    Arunachalam, Ashwini
    Gazit, Sivan
    Hoshen, Moshe
    Chodick, Gabriel
    Siegelmann-Danieli, Nava
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [26] Biomarker testing patterns and use of targeted therapy in Medicare Fee-for-Service (FFS) beneficiaries newly diagnosed with metastatic non-small cell lung cancer (mNSCLC).
    Patel, Anik
    Jamotte, Aurelien
    Matsuda, Tara
    Das, Partha Manas
    Elkhouly, Ehab
    Xi, Ann
    Jones, Barton
    Murunga, Anne
    Petrilla, Allison
    Markward, Nathan
    Stevinson, Kendall Lee
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29)
  • [27] Real-world KRAS testing and treatment utilization among patients with metastatic non-small cell lung cancer
    Blanc, Simon
    Vasudevan, Anupama
    Gart, Mike
    Sura, Teena
    Shrivastava, Aryamaan
    Varughese, Prateesh
    Scott, Jeffrey A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [28] LKB1 Mutations in Metastatic Non-Small Cell Lung Cancer (mNSCLC): Prognostic Value in the Real World
    Golozar, A.
    Collins, J.
    Fraeman, K.
    Nordstrom, B.
    Mcewen, R.
    Shire, N.
    Higgs, B.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S223 - S224
  • [29] Challenges in the Use of Targeted Therapies in Non-Small Cell Lung Cancer
    Rivera-Concepcion, Joel
    Uprety, Dipesh
    Adjei, Alex A.
    CANCER RESEARCH AND TREATMENT, 2022, 54 (02): : 315 - 329
  • [30] REAL-WORLD UTILIZATION PATTERNS AND OUTCOMES OF BIOMARKER TESTING FOR NON-SMALL CELL LUNG CANCER IN AN INTEGRATED HEALTHCARE SYSTEM
    Alcasid, Nathan
    Tupper, Haley I.
    Sarovar, Varada
    Dong, Huyun
    Dyer, Wendy
    Yang, Jingrong
    Patel, Ashish
    Ashiku, Simon K.
    Sakoda, Lori
    Velotta, Jeffrey B.
    CHEST, 2024, 166 (04) : 4368A - 4369A
12345